These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights. Al-Warhi T; El Kerdawy AM; Said MA; Albohy A; Elsayed ZM; Aljaeed N; Elkaeed EB; Eldehna WM; Abdel-Aziz HA; Abdelmoaz MA Drug Des Devel Ther; 2022; 16():1457-1471. PubMed ID: 35607598 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and anticancer evaluation of 1H-pyrazolo[3,4-d]pyrimidine derivatives as potent EGFR Gaber AA; Bayoumi AH; El-Morsy AM; Sherbiny FF; Mehany ABM; Eissa IH Bioorg Chem; 2018 Oct; 80():375-395. PubMed ID: 29986185 [TBL] [Abstract][Full Text] [Related]
8. Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAF Abou-Zied HA; Beshr EAM; Gomaa HAM; Mostafa YA; Youssif BGM; Hayallah AM; Abdel-Aziz M Arch Pharm (Weinheim); 2023 Apr; 356(4):e2200464. PubMed ID: 36526595 [TBL] [Abstract][Full Text] [Related]
9. Exploration of thiazolidine-2,4-diones as tyrosine kinase inhibitors: Design, synthesis, ADMET, docking, and antiproliferative evaluations. Aziz NAAM; George RF; El-Adl K; Mahmoud WR Arch Pharm (Weinheim); 2023 Mar; 356(3):e2200465. PubMed ID: 36403198 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of new series of hexahydroquinoline and fused quinoline derivatives as potent inhibitors of wild-type EGFR and mutant EGFR (L858R and T790M). Shaheen MA; El-Emam AA; El-Gohary NS Bioorg Chem; 2020 Dec; 105():104274. PubMed ID: 33339080 [TBL] [Abstract][Full Text] [Related]
11. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells. Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057 [TBL] [Abstract][Full Text] [Related]
12. Development of adamantane scaffold containing 1,3,4-thiadiazole derivatives: Design, synthesis, anti-proliferative activity and molecular docking study targeting EGFR. Wassel MMS; Ammar YA; Elhag Ali GAM; Belal A; Mehany ABM; Ragab A Bioorg Chem; 2021 May; 110():104794. PubMed ID: 33735711 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of potent EGFR kinase inhibitors against 19D/T790M/C797S mutation. Su Z; Yang T; Wang J; Lai M; Tong L; Wumaier G; Chen Z; Li S; Li H; Xie H; Zhao Z Bioorg Med Chem Lett; 2020 Aug; 30(16):127327. PubMed ID: 32631532 [TBL] [Abstract][Full Text] [Related]
14. Design and Synthesis of Non-Covalent Imidazo[1,2- Kumar M; Joshi G; Arora S; Singh T; Biswas S; Sharma N; Bhat ZR; Tikoo K; Singh S; Kumar R Molecules; 2021 Mar; 26(5):. PubMed ID: 33803355 [TBL] [Abstract][Full Text] [Related]
15. Novel Pyrazoloquinolin-2-ones: Design, synthesis, docking studies, and biological evaluation as antiproliferative EGFR-TK inhibitors. Elbastawesy MAI; Aly AA; Ramadan M; Elshaier YAMM; Youssif BGM; Brown AB; El-Din A Abuo-Rahma G Bioorg Chem; 2019 Sep; 90():103045. PubMed ID: 31212178 [TBL] [Abstract][Full Text] [Related]